Shaoyuan Li

Dr. Shaoyuan Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
NZNingyi Bs Zou
Ningyi Bs Zou
QZQing Bs Zhou
Qing Bs Zhou
YZYuzhengheng Bs Zhang
Yuzhengheng Bs Zhang
CXChen Xin
Chen Xin
YWYifei Wang
Yifei Wang
SLShaoyuan Li
Shaoyuan Li
Currently, clinical practice and scientific research mostly revolve around a single disease or system, but the single disease-oriented diagnostic and therapeutic paradigm needs to be revised. This review describes how transcutaneous auricular vagus nerve stimulation (taVNS), a novel non-invasive neuromodulation approach, connects the central and peripheral systems of the body. Through stimulation of the widely distributed vagus nerve from the head to the abdominal cavity, this therapy can improve and treat central system disorders, peripheral system disorders, and central-peripheral comorbidities caused by autonomic dysfunction. In the past, research on taVNS has focused on the treatment of central system disorders by modulating this brain nerve. As the vagus nerve innervates the heart, lungs, liver, pancreas, gastrointestinal tract, spleen and other peripheral organs, taVNS could have an overall modulatory effect on the region of the body where the vagus nerve is widespread. Based on this physiological basis, the authors summarize the existing evidence of the taVNS ability to regulate cardiac function, adiposity, glucose levels, gastrointestinal function, and immune function, among others, to treat peripheral system diseases, and complex diseases with central and peripheral comorbidities. This review shows the successful examples and research progress of taVNS using peripheral neuromodulation mechanisms from more perspectives, demonstrating the expanded scope and value of taVNS to provide new ideas and approaches for holistic therapy from both central and peripheral perspectives.

5 November 2024 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
YZYuzhengheng Zhang
Yuzhengheng Zhang
NZNingyi Zou
Ningyi Zou
CXChen Xin
Chen Xin
YWYifei Wang
Yifei Wang
ZZZixuan Zhang
Zixuan Zhang
SLShaoyuan Li
Shaoyuan Li
Background: Melatonin (MLT) and its receptor deficiency have been shown to be associated with type 2 diabetes mellitus (T2DM). Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive alternative intervention for patients suffering from hyperglycemia. Here, we aimed to investigate the role of taVNS on blood glucose modulation via intestinal melatonin receptors (MRs) and MLT secretion in hyperglycemia.Methods: Adult male Zucker diabetes fatty (ZDF) rats and Zucker lean (ZL) littermates were used. Forty ZDF rats were randomized into ZDF, taVNS, Px + taVNS and Lu + Px + taVNS groups (Px: pinealectomy, Lu: Luzindole). ZL rats served as a control group for comparison with ZDF rats without involvement in the taVNS intervention. Thirty min-taVNS interventions (2/15 Hz, 2 mA, 30 min/days) were administered once daily under anesthesia for 3 consecutive weeks in taVNS, Px + taVNS and Lu + Px + taVNS groups. Body weight and fasting blood glucose (FBG) were measured weekly in all rats, and real-time blood glucose was tested in the ZL and ZDF groups before, during and after the taVNS intervention. Plasma MLT concentration and the expression of MRs in the duodenum, jejunum and ileum were measured by the end of experiments.Results: Compared with the ZL group, the level of FBG and body weight increased (all p < 0.01), plasma MLT secretion and the expression of MRs in duodenum, jejunum and ileum of ZDF rats decreased obviously (all p < 0.05), respectively. TaVNS can significantly reverse the hyperglycemia by regulating the non-pineal-derived MLT and MRs system in Px + taVNS group. Compared with the ZDF group, the expression of different intestinal MRs in the taVNS group was increased and more compactly arranged (both p < 0.05), the level of plasma MLT secretion was up-regulated (p < 0.01), and FBG and body weight were decreased (both p < 0.01). Meanwhile, after taVNS intervention in rats in the Px + taVNS group, we observed an increase in MLT secretion and the number of intestinal MRs compared with the taVNS group (all p > 0.05). In contrast, ZDF rats in which the pineal gland was excised by taVNS intervention and injected with the MRs antagonist Luzindole did not show these changes.Conclusion: The glucose reduction effect of taVNS may be related to regulating MLT levels and expressing intestinal MRs.

2 August 2024 in International Journal of Surgery
Verified
Journal Article
Open access
SLShaoyuan Li
Shaoyuan Li
NZNingyi Bs Zou
Ningyi Bs Zou
BFBo-wen Feng
Bo-wen Feng
Claire-Marie RangonClaire-Marie Rangon
Claire-Marie Rangon
JHJuan Han
Juan Han
Pei-jing RongPei-jing Rong
Pei-jing Rong
An abstract is unavailable. This article is available as a PDF only.

23 September 2024 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
XXXue Xiao
Xue Xiao
JSJifei Sun
Jifei Sun
JTJing Tian
Jing Tian
XSXu Sun
Xu Sun
CYChunhong Yang
Chunhong Yang
XHXiaobing Hou
Xiaobing Hou

2 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Jinqiang ZhangJinqiang Zhang
Jinqiang Zhang
Pei-jing RongPei-jing Rong
Pei-jing Rong
LZLijuan Zhang
Lijuan Zhang
HHHui He
Hui He
TZTao Zhou
Tao Zhou
ZYZili You
Zili You
Adult neurogenesis in the dentate gyrus of the hippocampus is regulated by specific groups of microglia and is functionally implicated in behavioral responses to stress. However, the role of microglia in modulating hippocampal neurogenesis in stress responses remains poorly understood. Here we investigated the effects of IL4-driven Arg1+microglia in the restoration of hippocampal neurogenesis and conferment of stress resilience. We found that low IL4 levels in the hippocampus of mice was associated with greater stress vulnerability and, conversely, overexpression of IL4 in the hippocampus induced a large number of Arg1+microglia and ameliorated stress-induced depressive-like behaviors. Knockdown of microglial IL4 receptors in the hippocampus of mice exacerbated the stress-induced inflammatory response and abolished the antidepressant effects of IL4 overexpression. Enhancement or inhibition of IL4 signaling in hippocampal microglia modulated neurogenesis, and blockade of neurogenesis abolished the resilience to stress-induced depression. We further show that IL4-activated microglia is associated with upregulation of BDNF levels and neurogenesis. Taken together, our findings suggest that IL4-driven microglia in the hippocampus trigger BDNF-dependent neurogenesis in response to chronic stress, helping protect against depressive-like symptoms. These findings identify the modulation of a specific microglial phenotype as a treatment strategy for mood disorders.In Brief: Zhang et al. show that IL4-induced Arg1+microglia restore hippocampal neurogenesis and promote resilience against stress in mice by increasing BDNF levels. Targeting microglia with immunomodulatory factors may be a strategy for treating mood disorders.Highlights: Vulnerability to stress in mice is associated with reduced IL4 signaling in the hippocampus Brain-derived IL4 promotes adult hippocampal neurogenesis and stress resistance by driving Arg1+microglia IL4-driven Arg1+microglia enhance hippocampal neurogenesis via a BDNF-dependent pathway

6 June 2024 in Gut Microbiota and Integrative Wellness
Verified
Journal Article
Open access
PDF file
CXChen Xin
Chen Xin
YZYuzhengheng Zhang
Yuzhengheng Zhang
JGJing Guo
Jing Guo
YWYu Wang
Yu Wang
YWYifei Wang
Yifei Wang
Pei-jing RongPei-jing Rong
Pei-jing Rong
Background: After more than two decades of development, transcutaneous auricular vagus nerve stimulation (taVNS) has surpassed its role as a mere alternative to VNS and is now applied to various disorders. This study presents a bibliometric analysis to evaluate the global scientific output of taVNS research, aiming to describe its current status and identify potential future trends. Methods: We conducted a systematic retrieval of taVNS-related studies published between 2000 and 2022 from the Web of Science database. VOSviewer was used to construct networks based on country/institution/author co-authorship, journal/reference co-citation analysis, literature citation analysis and keyword co-occurrence. Results: A total of 523 relevant articles and reviews were included. Since 2012, there has been a rapid increase in publications and citations. China emerged as the leading contributor in terms of publication output, while Germany had the highest number of citations. Interestingly, research groups from different countries exhibited distinct research ideas and characteristics concerning taVNS, yet collaboration between these groups remained limited. Through a focused examination of key aspects in this field, we identified significant opportunities for the future advancement of taVNS. Conclusion: This bibliometric analysis emphasizes the interest in and recognition of taVNS as a therapeutic intervention and identifies broader clinical applications, more precise stimulation, and the development and commercialization of wearable devices as key opportunities and challenges for the future.